What this means
This trial plans to test two gut-focused treatments on signs of aging in immune cells. It has not started enrolling people, and no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 40 and over
- Where
- 1 site, including Louisiana
The science
- Registered title
- Precision Microbiota Interventions for Senoreduction Trial
- Trial ID
- NCT07462767 ↗
- Phase
- PHASE 1 / PHASE 2
- Study type
- interventional
- Conditions
- HIV Infections, Alcohol Drinking, Aging, Immunosenescence
- What is tested
- Limosilactobacillus reuteri, Blueberry extract
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Ages
- 40 Years to no maximum
- Dates
- First posted Mar 10, 2026 · updated Oct 1, 2026
Registry summary
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Sites (1)
- LSU Health, New Orleans, Louisiana, United States